{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T23:51:57Z","timestamp":1782345117661,"version":"3.54.5"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2023,3,18]],"date-time":"2023-03-18T00:00:00Z","timestamp":1679097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,3,18]],"date-time":"2023-03-18T00:00:00Z","timestamp":1679097600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Hochschule Mannheim"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Health Care and Philos"],"published-print":{"date-parts":[[2023,6]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>New technologies create new complexities. Since non-invasive prenatal tests (NIPTs) were first introduced, keeping pace with complexity constitutes an ongoing task for medical societies, politics, and practice. NIPTs analyse the chromosomes of the fetus from a small blood sample. Initially, NIPTs were targeted at detecting trisomy 21 (Down syndrome): meanwhile there are sequencing techniques capable of analysing the entire genome of the unborn child. These yield findings of unclear relevance for the child\u2019s future life, resulting in new responsibility structures and dilemmas for the parents-to-be.<\/jats:p><jats:p>The industry\u2019s marketing strategies overemphasize the benefits of the tests while disregarding their consequences. This paper chooses the opposite path: starting with the underestimated consequences, it focuses on adverse developments and downsides. Disparities, paradoxes, and risks associated with NIPTs are illustrated, ethical conflicts described. Indications that new technologies developed to solve problems create new ones are examined. In the sense of critical thinking, seemingly robust knowledge is scrutinized for uncertainties and ambiguities. It analyses how the interplay between genetic knowledge and social discourse results in new dimensions of responsibility not only for parents-to-be, but also for decision-makers, authorities, and professional societies, illustrated by a review of different national policies and implementation programmes. As shown by the new NIPT policy in Norway, the consequences can be startling. Finally, a lawsuit in the United States illustrates how an agency can risk forfeiting its legitimation in connection with the inaccuracy of NIPTs.<\/jats:p>","DOI":"10.1007\/s11019-023-10143-1","type":"journal-article","created":{"date-parts":[[2023,3,18]],"date-time":"2023-03-18T00:03:33Z","timestamp":1679097813000},"page":"271-282","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["\u201cOverestimated technology \u2013 underestimated consequences\u201d \u2013 reflections on risks, ethical conflicts, and social disparities in the handling of non-invasive prenatal tests (NIPTs)"],"prefix":"10.1007","volume":"26","author":[{"given":"Marion","family":"Baldus","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,3,18]]},"reference":[{"key":"10143_CR1","doi-asserted-by":"crossref","unstructured":"Allyse, M., M. A. Minear, E. Berson, S. Sridhar, M. Rote, A. Hung, and S. Chandrasekharan. 2015. Non-invasive prenatal testing: a review of international implementation and challenges. International Journal of Women\u2019s Health 2015: 7: 113\u2013126.","DOI":"10.2147\/IJWH.S67124"},{"key":"10143_CR3","doi-asserted-by":"crossref","unstructured":"Baldus, M. 2018. Verantwortete Elternschaft? Dilemmata des Elternwerdens im Kontext pr\u00e4nataler Diagnostik. Psychosozial, Jg. 41, Heft 1: 8\u201317.","DOI":"10.30820\/0171-3434-2018-1-8"},{"key":"10143_CR4","first-page":"111","volume":"237","author":"M Baldus","year":"2016","unstructured":"Baldus, M. 2016. Dominanz des Marktes. Gen-ethischer Informationsdienst (GiD) 237: 111\u2013113.","journal-title":"Gen-ethischer Informationsdienst (GiD)"},{"key":"10143_CR5","volume-title":"Von der diagnose zur Entscheidung. Eine Analyse von Entscheidungsprozessen f\u00fcr das Austragen der Schwangerschaft nach der pr\u00e4natalen Diagnose Down-Syndrom","author":"M Baldus","year":"2006","unstructured":"Baldus, M. 2006. Von der Diagnose zur Entscheidung. Eine Analyse von Entscheidungsprozessen f\u00fcr das Austragen der Schwangerschaft nach der pr\u00e4natalen Diagnose Down-Syndrom. Bad Heilbrunn: Klinkhardt."},{"key":"10143_CR6","unstructured":"Barron\u2019s, Newsfile. 2022. SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Natera, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of June 27, 2022 - (NTRA) https:\/\/www.barrons.com\/articles\/shareholder-alert-the-gross-law-firm-notifies-shareholders-of-natera-inc-of-a-class-action-lawsuit-and-a-lead-plaintiff-deadline-of-june-27-2022-ntra-01655378179. Accessed 7 August 2022."},{"key":"10143_CR7","doi-asserted-by":"publisher","unstructured":"Benn, P., S. E. Plon, and D. W. Bianchi. 2019. Current Controversies in Prenatal Diagnosis 2: NIPT results suggesting maternal cancer should always be disclosed. Prenat Diagn 2019 Apr;39(5):339\u2013343. https:\/\/doi.org\/10.1002\/pd.5379. Epub 2018 Dec 10. PMID: 30398677; PMCID: PMC6714972.","DOI":"10.1002\/pd.5379"},{"issue":"2","key":"10143_CR8","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1038\/gim.2012.113","volume":"15","author":"BA Bernhardt","year":"2013","unstructured":"Bernhardt, B. A., D. Soucier, K. Hanson, M. S. Savage, L. Jackson, and R. J. Wapner. 2013. Women\u00b4s experiences receiving abnormal prenatal chromosomal microarray testing results. Genet Med 15 (2): 139\u2013145.","journal-title":"Genet Med"},{"key":"10143_CR9","doi-asserted-by":"publisher","unstructured":"Bianchi, D. W. 2019. Turner syndrome: New insights from prenatal genomics and transcriptomics. AmJ Med Genet Part C. 2019;181\u00a0C:29\u201333.https:\/\/doi.org\/10.1002\/ajmg.c.31675.","DOI":"10.1002\/ajmg.c.31675"},{"key":"10143_CR10","unstructured":"Bioteknologiradet: Fosterdiagnostikk. https:\/\/www.bioteknologiradet.no\/termaer\/fosterdiagnostikk\/. Accessed 12 July 2022."},{"key":"10143_CR11","doi-asserted-by":"publisher","unstructured":"Bilardo, C. M. 2021. \u201cThe implementation of non-invasive prenatal testing (NIPT) in the Netherlands\u201d Journal of Perinatal Medicine, vol.\u00a049, no. 8, 2021, pp.\u00a0941\u2013944. https:\/\/doi.org\/10.1515\/jpm-2021-0290.","DOI":"10.1515\/jpm-2021-0290"},{"key":"10143_CR12","unstructured":"Bschir, K. 2018. Die Verantwortung der Wissenschaft. https:\/\/philosophie.ch\/philosophie\/highlights\/philosophie-aktuell\/die-verantwortung-der-wissenschaft. Accessed 16 June 2022."},{"key":"10143_CR14","unstructured":"EUR-Lex. Ensuring the safety and performance of in vitro diagnostic medical devices. https:\/\/eur-lex.europa.eu\/EN\/legal-content\/summary\/ensuring-the-safety-and-performance-of-in-vitro-diagnostic-medical-devices.html. Accessed 30 January 2023."},{"key":"10143_CR15","unstructured":"EUROCAT. Prevalence charts and tables. https:\/\/eu-rd-platform.jrc.ec.europa.eu\/eurocat\/eurocat-data\/prevalence_en. Accessed 30 January 2023."},{"key":"10143_CR16","unstructured":"Food and Drug Administration (FDA). 2022. Genetic Non-Invasive Prenatal Screening Tests May Have False Results: FDA Safety Communication. https:\/\/www.fda.gov\/medical-devices\/safety-communications\/genetic-non-invasive-prenatal-screening-tests-may-have-false-results-fda-safety-communication. Accessed 20 June 2022."},{"key":"10143_CR18","doi-asserted-by":"publisher","unstructured":"Gadsb\u00f8ll, K., O. B. Petersen, V. Gatinois, H. Strange, B. Jacobsson, and R. Wapner, et al. 2020. Current use of noninvasive prenatal testing in Europe, Australia and the USA: A graphical presentation. Acta Obstet Gynecol Scand. 2020; 99:722\u2013730. https:\/\/doi.org\/10.1111\/aogs.13841.","DOI":"10.1111\/aogs.13841"},{"key":"10143_CR19","doi-asserted-by":"publisher","unstructured":"Gammon, B. L., C. Jaramillo, K. A. Riggan, and M. Allyse. 2018. Decisional regret in women receiving high risk or inconclusive prenatal cell-free DNA screening results. The Journal of Maternal-Fetal & Neonatal Medicine, 2018; 33:8, 1412\u20131418. https:\/\/doi.org\/10.1080\/14767058.2018.1519541. Accessed 12 July 2022.","DOI":"10.1080\/14767058.2018.1519541"},{"key":"10143_CR20","unstructured":"Gemeinsamer Bundesausschuss (G-BA). 2021. Richtlinien des Gemeinsamen Bundesausschusses \u00fcber die \u00e4rztliche Betreuung w\u00e4hrend der Schwangerschaft und nach der Entbindung (\u201eMutterschafts-Richtlinien\u201c). https:\/\/www.g-ba.de\/downloads\/62-492-2676\/Mu-RL_2021-09-16_iK-2022-01-01.pdf. Accessed 12 July 2022."},{"key":"10143_CR21","unstructured":"Gemeinsamer Bundesausschuss (G-BA). 2019a. Beschluss des Gemeinsamen Bundesausschusses \u00fcber eine \u00c4nderung der Mutterschaftsrichtlinien. https:\/\/www.g-ba.de\/downloads\/39-261-3955\/2019-09-19_B_Mu-RL_NIPT_WZ_.pdf. Accessed 12 July 2022."},{"key":"10143_CR22","unstructured":"Gemeinsamer Bundesausschuss (G-BA). 2019b. Tragende Gr\u00fcnde zum Beschluss des Gemeinsamen Bundesausschusses \u00fcber eine \u00c4nderung der Mutterschafts-Richtlinien (Mu-RL). https:\/\/www.g-ba.de\/downloads\/40-268-6007\/2019-09-19_B_Mu-RL_NIPT_TrG.pdf. Accessed 12 July 2022."},{"key":"10143_CR24","doi-asserted-by":"crossref","unstructured":"Glad, R. 2022. Prenatal testing \u2013 universal access? Tiddskrift for Den norske legeforening. https:\/\/tidsskriftet.no\/en\/2022\/05\/editorial\/prenatal-testing-universal-access. Accessed 30 January 2023.","DOI":"10.4045\/tidsskr.22.0273"},{"key":"10143_CR25","unstructured":"GlobeNewswire. 2022. United States non-invasive prenatal testing (NIPT) market size to amass USD 2557 million by 2030. https:\/\/www.globenewswire.com\/en\/news-release\/2022\/04\/14\/2422530\/0\/en\/United-States-non-invasive-prenatal-testing-NIPT-market-size-to-amass-USD-2557-million-by-2030.html#:~:text=Pune%2\u00a0C%20India%2\u00a0C%20April%2014%2\u00a0C,end%20of%20the%20analysis%20period. Accessed 23 January 2023."},{"key":"10143_CR26","unstructured":"Han, A. P. 2022. Natera hit with multiple class action suits over \u02bbunreliable\u02bc NIPT results. https:\/\/www.Genomeweb.com\/molecular-diagnostics\/natera_hit_multiple_class-action-suits-over-unreliable-nipt-results#.YrGxxHZBxPY. Accessed 26 June 2022."},{"key":"10143_CR27","doi-asserted-by":"publisher","unstructured":"Hashiloni-Dolev, Y., T. Nov-Kleiman, and A. Raz. 2019. Pandora\u2019s pregnancy: NIPT, CMA, and genome sequencing \u2013 a new era for prenatal genetic testing. Prenatal Diagnosis. 1\u20137. https:\/\/doi.org\/10.1002\/pd.5495.","DOI":"10.1002\/pd.5495"},{"key":"10143_CR28","doi-asserted-by":"publisher","unstructured":"Holloway, K., N. Simms, A. Fiona, and F. A. Miller. 2022. The Market in Noninvasive Prenatal Tests and the Message to Consumers: Exploring Responsibility. The Hastings Center Report. Volume52, Issue2 March-April 2022: 49\u201357. https:\/\/doi.org\/10.1002\/hast.1329. Accessed 30 January 2023.","DOI":"10.1002\/hast.1329"},{"key":"10143_CR29","doi-asserted-by":"publisher","unstructured":"Hu, H., L. Wang, and J. Wu, et al. 2019. Noninvasive prenatal testing for chromosome aneuploidies and subchromosomal microdeletions\/microduplications in a cohort of 8141 single pregnancies. Hum Genomics 13, 14 (2019). https:\/\/doi.org\/10.1186\/s40246-019-0198-2.","DOI":"10.1186\/s40246-019-0198-2"},{"key":"10143_CR30","unstructured":"Klein, M. 2022. Pr\u00e4nataldiagnostik im europ\u00e4ischen Vergleich. Welche Untersuchungen sind wo m\u00f6glich? Die Debatte. https:\/\/www.die-debatte.org\/praenataldiagnostik-laendervergleich\/ Accessed 7 August 2022."},{"key":"10143_CR31","unstructured":"Kliff, S., and A. Bhatia. 2022. When They Warn of Rare Disorders, These Prenatal Tests Are Usually Wrong. The New York Times, 1 January. https:\/\/www.nytimes.com\/2022\/01\/01\/upshot\/pregnancy-birth-genetic-testing.html. Accessed 10 January 2022."},{"key":"10143_CR32","doi-asserted-by":"publisher","DOI":"10.5445\/IR\/1000102614","volume-title":"Aktueller stand und Entwicklungen der Pr\u00e4nataldiagnostik. Endbericht zum Monitoring. TAB-Arbeitsbericht nr. 184","author":"A Kolleck","year":"2019","unstructured":"Kolleck, A., and A. Sauter. 2019. Aktueller Stand und Entwicklungen der Pr\u00e4nataldiagnostik. Endbericht zum Monitoring. TAB-Arbeitsbericht nr. 184. Berlin: Hrsg.: B\u00fcro f\u00fcr Technikfolgen-Absch\u00e4tzung beim Deutschen Bundestag. https:\/\/doi.org\/10.5445\/IR\/1000102614."},{"key":"10143_CR33","unstructured":"Kortas, O. 2022. Ein letzter Weg. ZEIT online. https:\/\/www.zeit.de\/2022\/33\/polen-schwangerschaftsabbruch-politik-medizin\/komplettansicht."},{"key":"10143_CR34","doi-asserted-by":"publisher","unstructured":"Kristalijn, S. A., K. White, D. Eerbeek, E. Kostenko, F. R. Grati, and C. M. Bilardo. 2022. Patient experience with non-invasive prenatal testing (NIPT) as a primary screen for aneuploidy in the Netherlands. BMC Pregnancy and Childbirth (2022) 22:782 https:\/\/doi.org\/10.1186\/s12884-022-05110-2. Accessed 30 January 2023.","DOI":"10.1186\/s12884-022-05110-2"},{"issue":"1","key":"10143_CR35","doi-asserted-by":"publisher","first-page":"5","DOI":"10.5324\/eip.v15i1.3816","volume":"15","author":"N Levold","year":"2021","unstructured":"Levold, N., M. Svingen, and I. Bruholt. 2021. Fosterdiagnostikk mellom medisin og etikk: Implementering av NIPT\u2013testen i et urolig politikkomr\u00e5de: Implementering av NIPT\u2013testen i et urolig politikkomr\u00e5de. Etikk I Praksis - Nordic Journal of Applied Ethics 15 (1): 5\u201324. https:\/\/doi.org\/10.5324\/eip.v15i1.3816.","journal-title":"Etikk I Praksis - Nordic Journal of Applied Ethics"},{"key":"10143_CR36","doi-asserted-by":"publisher","unstructured":"Magelssen, M., B. Solberg, M. Supphellen, and G. Haugen. 2018. Attitudes to prenatal screening among Norwegian citizens: liberality, ambivalence and sensitivity. BMC Medical Ethics (2018) 19:80. https:\/\/doi.org\/10.1186\/s12910-018-0319-9.","DOI":"10.1186\/s12910-018-0319-9"},{"key":"10143_CR37","unstructured":"Nuffield Council on Bioethics. 2017. Non-invasive Prenatal Testing: Ethical Issues. London. https:\/\/www.nuffieldbioethics.org\/publications\/non-invasive-prenatal-testing. Accessed 30 January 2023."},{"key":"10143_CR38","unstructured":"Ochsenbein-K\u00f6lble, N., T. Burkhardt, L. Raio, Y. Vial, D. Surbek, S. Tercanli, A. Rauch, I. Filges, and S. Fokstuen. 2018. Expertenbrief No 53: Pr\u00e4natale nicht-invasive Risikoabsch\u00e4tzung fetaler Aneuploidien. Gyn\u00e9cologie Suisse."},{"key":"10143_CR39","unstructured":"Paul-Ehrlich-Institute. Vigilance of In Vitro Diagnostics (IVD). https:\/\/www.pei.de\/EN\/medicine-safety\/ivd-vigilance\/ivd-vigilance-node.html. Accessed 30 January 2023."},{"key":"10143_CR40","doi-asserted-by":"publisher","unstructured":"Perrot, A., and H. Ruth. 2022. Preserving women\u2019s reproductive autonomy while promoting the rights of people with disabilities?: The case of Heidi Crowter and Maire Lea-Wilson in the light of NIPT debates in England, France and Germany. J Med Ethics Epub ahead of print11 March 2022. https:\/\/doi.org\/10.1136\/medethics-2021-107912.","DOI":"10.1136\/medethics-2021-107912"},{"key":"10143_CR41","doi-asserted-by":"publisher","unstructured":"Ravitsky, V., M.-C. Roy, H. Haidar, L. Hennemann, J. Marshall, A. J. Newson, O. M. Y. Ngan, and T. Nov-Klaiman. 2021. The Emergence and Global Spread of Noninvasive Prenatal Testing. Annu. Rev. Genom. Hum. Genet. 2021. 22: 309 \u2013 38. https:\/\/doi.org\/10.1146\/annurev-genom-083118-015053.","DOI":"10.1146\/annurev-genom-083118-015053"},{"key":"10143_CR42","unstructured":"REHADAT Statistik. 2021. Statistik der schwerbehinderten Menschen. https:\/\/www.rehadat-statistik.de\/statistiken\/behinderung\/schwerbehindertenstatistik\/. Accessed 15 August 2022."},{"key":"10143_CR43","doi-asserted-by":"crossref","unstructured":"Reinsperger, I. 2022. Regulation and financing of prenatal screening and diagnostic examinations for fetal anomalies in selected European countries. AIHTA Policy Brief No.: 12, 2022. Vienna: HTA Austria \u2013 Austrian Institute for Health Technology Assessment GmbH.","DOI":"10.1093\/eurpub\/ckac130.046"},{"key":"10143_CR44","unstructured":"Richter-Kuhlmann, E. 2022. Pr\u00e4nataldiagnostik. Start einer neuen \u00c4ra. Dtsch Arztebl 2022; 119(24): A-1075 \/ B-903."},{"key":"10143_CR45","doi-asserted-by":"publisher","unstructured":"Salomon, L. J., A. Sotiriadis, C. B. Wulff, A. Odibo, and R. Akolekar. 2019. Risk of miscarriage following amniocentesis or chorionic villus sampling: systematic review of literature and updated meta-analysis. Ultrasound Obstet Gynecol 2019; 54: 442\u2013451. DOI: https:\/\/doi.org\/10.1002\/uog.20353.","DOI":"10.1002\/uog.20353"},{"key":"10143_CR46","doi-asserted-by":"publisher","unstructured":"Salvesen, K. A. B., R. Glad, and V. Sitras. 2022. Controversies in implementing non-invasive prenatal testing in a public antenatal care program. Acta Obstet Gynecol Scand. 2022; 101: 577\u2013580. DOI: https:\/\/doi.org\/10.1111\/aogs.14351.","DOI":"10.1111\/aogs.14351"},{"key":"10143_CR47","doi-asserted-by":"publisher","unstructured":"Schidel, R. 2020. Pr\u00e4nataldiagnostik als Instanz von struktureller Diskriminierung? \u00dcberlegungen zur Debatte um den PraenaTest und seine Auswirkungen auf Menschen mit Behinderung. Zeitschrift f\u00fcr Praktische Philosophie Band 7, Heft 1, 2020, S.\u00a0231\u2013264 www.praktische-philosophie.orghttps:\/\/doi.org\/10.22613\/zfpp\/7.1.8.","DOI":"10.22613\/zfpp\/7.1.8"},{"key":"10143_CR48","doi-asserted-by":"crossref","unstructured":"Seavilleklein, V. 2009. Challenging the Rhetoric of Choice in Prenatal Screening. Bioethics 23 (2009) H. 1, 68\u201377.","DOI":"10.1111\/j.1467-8519.2008.00674.x"},{"key":"10143_CR49","doi-asserted-by":"publisher","unstructured":"Skirton, H., L. Goldsmith, L. Jackson, C. Lewis, and L. S. Chitty. 2015. Non-invasive prenatal testing for aneuploidy: a systematic review of Internet advertising to potential users by commercial companies and private health providers. Prenat Diagn. 2015 Dec;35(12):1167-75. DOI: https:\/\/doi.org\/10.1002\/pd.4673. Epub 2015 Sep 7.","DOI":"10.1002\/pd.4673"},{"key":"10143_CR50","doi-asserted-by":"publisher","unstructured":"Stein, Z., M. Susser, and A. V. Gutermann. 1973. Screening programme for prevention of Down\u2019s syndrome. Lancet. 1973 Feb 10;1(7798):305 \u2013 10. doi: https:\/\/doi.org\/10.1016\/s0140-6736(73)91551-1.","DOI":"10.1016\/s0140-6736(73)91551-1"},{"key":"10143_CR51","doi-asserted-by":"publisher","unstructured":"Steinfort, K., E. Van Houtven, Y. Jacquemy, B. Blaumeister, and P. Loquet. 2021. Difference in Procedure-Related Risk of Miscarriage between Early and Mid-Trimester Amniocentesis: A Retrospective Cohort Study. Diagnostics 2021, 11(6), 1098; https:\/\/doi.org\/10.3390\/diagnostics11061098.","DOI":"10.3390\/diagnostics11061098"},{"issue":"1","key":"10143_CR52","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1177\/0959353516679688","volume":"27","author":"N Stephenson","year":"2017","unstructured":"Stephenson, N., C. Mills, and K. McLeod. 2017. \u201cSimply providing information\u201d: negotiating the ethical dilemmas of obstetric ultrasound, prenatal testing and selective termination of pregnancy. Feminism & Psychology 27 (1): 72\u201391. https:\/\/doi.org\/10.1177\/0959353516679688.","journal-title":"Feminism & Psychology"},{"issue":"6","key":"10143_CR53","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1016\/j.ajhg.2019.10.005","volume":"5","author":"KRM van der Meij","year":"2019","unstructured":"van der Meij, K. R. M., E. A. Sistermans, M. V. E. Macville, S. J. C. Stevens, C. J. Bax, M. N. Bekker, C. M. Bilardo, E. M. J. Boon, M. Boter, K. E. M. Diderich, C. E. M. de Die-Smulders, L. K. Duin, B. H. W. Faas, I. Feenstra, M. C. Haak, M. J. V. Hoffer, N. S. den Hollander, I. H. I. M. Hollink, F. S. Jehee, M. F. C. M. Knapen, A. J. A. Kooper, I. M. van Langen, K. D. Lichtenbelt, I. H. Linskens, M. C. van Maarle, D. Oepkes, M. J. Pieters, G. H. Schuring-Blom, E. Sikkel, B. Sikkema-Raddatz, D. F. C. M. Smeets, M. I. Srebniak, R. F. Suijkerbuijk, G. M. Tan-Sindhunata, A. J. E. M. van der Ven, S. L. van Zelderen-Bhola, L. Henneman, R. H. Galjaard, D. Van Opstal, M. M. Weiss, and NIPT Consortium Dutch. 2019 Dec. TRIDENT-2: national implementation of genome-wide non-invasive prenatal testing as a first-tier screening test in the Netherlands. American Journal Of Human Genetics 5 (6): 1091\u20131101. doi:https:\/\/doi.org\/10.1016\/j.ajhg.2019.10.005. Epub 2019 Nov 7. PMID: 31708118; PMCID: PMC6904791. 105 ).","journal-title":"American Journal Of Human Genetics"},{"key":"10143_CR54","doi-asserted-by":"publisher","unstructured":"van Prooyen Schuurman, L. Sistermans, E. A. Van Opstal, D. Henneman, L. Bekker, M. N. Bax, and C. J. Peters, M.J. et al. 2022. Clinical impact of additional findings detected by genome-wide non-invasive prenatal testing: Follow-up results of the TRIDENT-2 study., Am J Hum Genet 109, 1140\u20131152 June 2, 2022. https:\/\/doi.org\/10.1016\/j.ajhg.2022.04.018.","DOI":"10.1016\/j.ajhg.2022.04.018"},{"key":"10143_CR55","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1002\/ijgo.12422","volume":"1441","author":"V Vinante","year":"2018","unstructured":"Vinante, V., B. Keller, E. A. Huhn, D. Huang, O. Lapaire, and G. Manegold-Brauer. 2018. Impact of nationwide health insurance coverage for non-invasive prenatal testing. International Journal of Gynaecology and Obstetrics 1441: 189\u2013193.","journal-title":"International Journal of Gynaecology and Obstetrics"},{"key":"10143_CR58","doi-asserted-by":"crossref","unstructured":"Wise, J. 2022. Non-invasive prenatal screening tests may give false results, warns US regulator. BMJ 2022.377o1031; 101136\/bmj.o1031.","DOI":"10.1136\/bmj.o1031"}],"container-title":["Medicine, Health Care and Philosophy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11019-023-10143-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11019-023-10143-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11019-023-10143-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,11]],"date-time":"2023-05-11T17:52:00Z","timestamp":1683827520000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11019-023-10143-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,18]]},"references-count":52,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["10143"],"URL":"https:\/\/doi.org\/10.1007\/s11019-023-10143-1","relation":{},"ISSN":["1386-7423","1572-8633"],"issn-type":[{"value":"1386-7423","type":"print"},{"value":"1572-8633","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,18]]},"assertion":[{"value":"15 February 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The author declares she has no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}